142 related articles for article (PubMed ID: 28772017)
1. An initiative to improve primary prevention of cardiovascular disease in adults with type II diabetes based on the ACC/AHA (2013) and ADA (2016) guidelines.
Garza L; Dols J; Gillespie M
J Am Assoc Nurse Pract; 2017 Oct; 29(10):606-611. PubMed ID: 28772017
[TBL] [Abstract][Full Text] [Related]
2. Implications of American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Guidelines on Statin Underutilization for Prevention of Cardiovascular Disease in Diabetes Mellitus Among Several US Networks of Community Health Centers.
Akhabue E; Rittner SS; Carroll JE; Crawford PM; Dant L; Laws R; Leo MC; Puro J; Persell SD
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28673901
[TBL] [Abstract][Full Text] [Related]
3. Comparing Guidelines for Statin Treatment in Canada and the United States.
Hennessy DA; Bushnik T; Manuel DG; Anderson TJ
J Am Heart Assoc; 2015 Jul; 4(7):. PubMed ID: 26175357
[TBL] [Abstract][Full Text] [Related]
4. Individualized Risk Communication and Outreach for Primary Cardiovascular Disease Prevention in Community Health Centers: Randomized Trial.
Persell SD; Brown T; Lee JY; Shah S; Henley E; Long T; Luther S; Lloyd-Jones DM; Jean-Jacques M; Kandula NR; Sanchez T; Baker DW
Circ Cardiovasc Qual Outcomes; 2015 Nov; 8(6):560-6. PubMed ID: 26555123
[TBL] [Abstract][Full Text] [Related]
5. Guideline-Based Statin Eligibility, Coronary Artery Calcification, and Cardiovascular Events.
Pursnani A; Massaro JM; D'Agostino RB; O'Donnell CJ; Hoffmann U
JAMA; 2015 Jul; 314(2):134-41. PubMed ID: 26172893
[TBL] [Abstract][Full Text] [Related]
6. Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines for cardiovascular disease prevention in a European cohort.
Kavousi M; Leening MJ; Nanchen D; Greenland P; Graham IM; Steyerberg EW; Ikram MA; Stricker BH; Hofman A; Franco OH
JAMA; 2014 Apr; 311(14):1416-23. PubMed ID: 24681960
[TBL] [Abstract][Full Text] [Related]
7. Applicability and potential clinical effects of 2013 cholesterol guidelines on major cardiovascular events.
Ko MJ; Kim YJ; Park CM; Lee SM; Lee WJ; Pencina MJ; Navar-Boggan AM; Park DW
Am Heart J; 2015 Sep; 170(3):598-605.e7. PubMed ID: 26385045
[TBL] [Abstract][Full Text] [Related]
8. Primary Prevention With Statins: ACC/AHA Risk-Based Approach Versus Trial-Based Approaches to Guide Statin Therapy.
Mortensen MB; Afzal S; Nordestgaard BG; Falk E
J Am Coll Cardiol; 2015 Dec; 66(24):2699-2709. PubMed ID: 26700832
[TBL] [Abstract][Full Text] [Related]
9. Application of the European Society of Cardiology, Adult Treatment Panel III and American College of Cardiology/American Heart Association guidelines for cardiovascular risk management in a French cohort of rheumatoid arthritis.
Tournadre A; Tatar Z; Pereira B; Chevreau M; Gossec L; Gaudin P; Soubrier M; Dougados M
Int J Cardiol; 2015 Mar; 183():149-54. PubMed ID: 25666124
[TBL] [Abstract][Full Text] [Related]
10. [Spanish interdisciplinary committee for cardiovascular disease prevention and the spanish society of cardiology position statement on dyslipidemia management. Differences between the European and american guidelines].
Lobos Bejarano JM; Galve E; Royo-Bordonada MÁ; Alegría Ezquerra E; Armario P; Brotons Cuixart C; Camafort Babkowski M; Cordero Fort A; Maiques Galán A; Mantilla Morató T; Pérez Pérez A; Pedro-Botet J; Villar Álvarez F; González-Juanatey JR;
Semergen; 2015 Apr; 41(3):149-57. PubMed ID: 25450438
[TBL] [Abstract][Full Text] [Related]
11. Implications of the 2013 ACC/AHA cholesterol guidelines for adults in contemporary cardiovascular practice: insights from the NCDR PINNACLE registry.
Maddox TM; Borden WB; Tang F; Virani SS; Oetgen WJ; Mullen JB; Chan PS; Casale PN; Douglas PS; Masoudi FA; Farmer SA; Rumsfeld JS
J Am Coll Cardiol; 2014 Dec; 64(21):2183-92. PubMed ID: 25447259
[TBL] [Abstract][Full Text] [Related]
12. Primary prevention of cardiovascular diseases by lipid-lowering treatment in German general practice: results from GPs ignoring guidelines and risk calculators.
Oriol-Zerbe C; Abholz HH
Eur J Gen Pract; 2007; 13(1):27-34. PubMed ID: 17366291
[TBL] [Abstract][Full Text] [Related]
13. A systematic examination of the 2013 ACC/AHA pooled cohort risk assessment tool for atherosclerotic cardiovascular disease.
Karmali KN; Goff DC; Ning H; Lloyd-Jones DM
J Am Coll Cardiol; 2014 Sep; 64(10):959-68. PubMed ID: 25190228
[TBL] [Abstract][Full Text] [Related]
14. Differences in primary cardiovascular disease prevention between the 2013 and 2016 cholesterol guidelines and impact of the 2017 hypertension guideline in the United States.
Egan BM; Li J; Davis RA; Fiscella KA; Tobin JN; Jones DW; Sinopoli A
J Clin Hypertens (Greenwich); 2018 Jun; 20(6):991-1000. PubMed ID: 29774988
[TBL] [Abstract][Full Text] [Related]
15. Increased statin eligibility based on ACC/AHA versus NCEP guidelines for high cholesterol management in Chile.
Echeverría G; Dussaillant C; Villarroel L; Rigotti A
J Clin Lipidol; 2016; 10(1):192-8.e1. PubMed ID: 26892136
[TBL] [Abstract][Full Text] [Related]
16. Translating guidelines to practice: findings from a multidisciplinary preventive cardiology programme in the west of Ireland.
Gibson I; Flaherty G; Cormican S; Jones J; Kerins C; Walsh AM; Costello C; Windle J; Connolly S; Crowley J
Eur J Prev Cardiol; 2014 Mar; 21(3):366-76. PubMed ID: 23884981
[TBL] [Abstract][Full Text] [Related]
17. Cholesterol treatment and changes in guidelines in an academic medical practice.
Schoen MW; Salas J; Scherrer JF; Buckhold FR
Am J Med; 2015 Apr; 128(4):403-9. PubMed ID: 25460526
[TBL] [Abstract][Full Text] [Related]
18. Meeting AHA/ACC secondary prevention goals in a vascular surgery practice: an opportunity we cannot afford to miss.
Kinikini D; Sarfati MR; Mueller MT; Kraiss LW; ;
J Vasc Surg; 2006 Apr; 43(4):781-7. PubMed ID: 16616237
[TBL] [Abstract][Full Text] [Related]
19. Application of new cholesterol guidelines to a population-based sample.
Pencina MJ; Navar-Boggan AM; D'Agostino RB; Williams K; Neely B; Sniderman AD; Peterson ED
N Engl J Med; 2014 Apr; 370(15):1422-31. PubMed ID: 24645848
[TBL] [Abstract][Full Text] [Related]
20. What the guidelines do not say: statin non-benefit groups.
Morris PB; McLain K
Curr Atheroscler Rep; 2015 Jan; 17(1):468. PubMed ID: 25404095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
